Exelixis Announces Third Quarter 2024 Financial Results and Provides Corporate Update
– Total Revenues of $539.5 million, Cabozantinib Franchise U.S. Net Product Revenues of $478.1 million – – GAAP Diluted EPS […]
– Total Revenues of $539.5 million, Cabozantinib Franchise U.S. Net Product Revenues of $478.1 million – – GAAP Diluted EPS […]
SCRANTON, Pa., Oct. 25, 2024 /PRNewswire/ — On October 25, 2024, the board of directors of Peoples Financial Services Corp.
Nilfisk provides preliminary financial figures for Q3 2024 and updates the financial outlook for 2024 following deteriorating demand in the